Quantcast
Tag archive for ‘drugs and supplements’
By The Dispatch On Saturday, December 17th, 2016
0 Comments

Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)

Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine.  More...

By Guest Author On Wednesday, November 23rd, 2016
0 Comments

Medication Side Effects Hospitalize Millions of People Each Year: What You Need to Know Today

Prescription medications have, over the years, no doubt saved many lives as well as improved the quality of life experienced by millions of people. However, something that doesn’t seem to get talked about enough, More...

By The Dispatch On Friday, October 28th, 2016
0 Comments

Why Drug Addiction Treatment Is More Important Than Ever

The seriousness of addiction and the effectiveness of treatment There are over 42 million people who suffer from drug addiction and sadly, most of those people are parents or expectant mothers. What addicts do not More...

By The Dispatch On Friday, October 28th, 2016
0 Comments

The Real Reasons Addiction Treatment Centers are Vital for Recovery

Addiction treatment centers are vital for recovery. When dealing with an addiction, it may seem like there is nowhere to turn for constructive help that actually works. It may also seem like controlling addiction More...

By Guest Author On Tuesday, July 12th, 2016
0 Comments

Is It A Good Idea To Buy Human Growth Hormone Supplements?

Every single person in the world wants to look as young as possible and the aging process is seen as the enemy by most of us. We simply want to stay young for as long as we can and appearance is always paramount. More...

By Guest Author On Wednesday, July 6th, 2016
1 Comment

When a parent’s addiction becomes a child’s depression

A parent struggling with addiction may assume that their addiction does not affect anyone else. In reality, their addiction can affect their children, causing them to develop depression and other mental health disorders More...

By The Dispatch On Tuesday, May 3rd, 2016
0 Comments

Antibiotics misused: CDC says 30 percent of antibiotic prescriptions unnecessary

At least 30 percent of antibiotics prescribed in the United States are unnecessary, according to new data published today in the Journal of the American Medical Association (JAMA) by the Centers for Disease Control More...

By The Dispatch On Monday, November 30th, 2015
0 Comments

Bristol-Myers Squibb’s, Empliciti, receives approval for the treatment of multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications. Multiple More...

By The Dispatch On Monday, November 23rd, 2015
1 Comment

Opdivo receives FDA nod to treat advanced form of kidney cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy. Photo/Madhero88 More...

By The Dispatch On Thursday, November 5th, 2015
0 Comments

HIV treatment, Genvoya, gets FDA nod

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment More...

By The Dispatch On Monday, January 26th, 2015
0 Comments

Generic version of Nexium approved to treat GERD

The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages More...

By The Dispatch On Wednesday, January 21st, 2015
0 Comments

New warnings issued for Alzheimer’s drug, Aricept: Health Canada

New warnings have been added to the prescribing information for the Alzheimer’s drug Aricept (donepezil) advising of the risk of two rare but potentially serious conditions: muscle breakdown (rhabdomyolysis) and More...

By The Dispatch On Wednesday, January 21st, 2015
2 Comments

Novartis psoriasis drug, Cosentyx, receives FDA approval

The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. PsoriasisPublic domain image/Bodiadub Psoriasis is a skin condition that causes More...

By The Dispatch On Friday, January 9th, 2015
2 Comments

Blood clot prevention drug, Savaysa, gets FDA approval

The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation More...

By The Dispatch On Tuesday, December 23rd, 2014
2 Comments

Novo Nordisk’s Saxenda receives FDA approval for chronic weight management treatment

The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The More...

By The Dispatch On Monday, December 22nd, 2014
0 Comments

Melanoma drug, Opdivo, gets FDA approval

The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who More...

By The Dispatch On Friday, December 19th, 2014
0 Comments

Ovarian cancer drug, Lynparza, receives FDA approval

The U.S. Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an More...

By Robert Herriman On Tuesday, December 16th, 2014
0 Comments

FDA warns of dangers of powdered pure caffeine

The US Food and Drug Administration (FDA) is advising the public about powdered pure caffeine that is sold on the internet and recommends people avoid these products. In an FDA Blog today, Director of FDA’s More...

By The Dispatch On Sunday, October 26th, 2014
0 Comments

FDA approves Obizur for treating hemophilia A bleeding episodes in adults

The U.S. Food and Drug Administration approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] More...

By The Dispatch On Wednesday, August 13th, 2014
0 Comments

Sleep drug, Belsomra, gets FDA nod

The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra is an orexin receptor antagonist and is More...

Interviews banner Dispatch Radio Logo 350x90

unnamed

passport2

Recent Posts

xcellediting
ProMedNetwork.com

Top Stories in Health